Granite Investment Partners, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Granite Investment Partners, LLC
- $2.26 Billion
- Q3 2024
A detailed history of Granite Investment Partners, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Granite Investment Partners, LLC holds 405,718 shares of AMPH stock, worth $15.9 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
405,718
Previous 397,514
2.06%
Holding current value
$15.9 Million
Previous $15.9 Million
23.83%
% of portfolio
0.87%
Previous 0.68%
Shares
7 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$232 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$106 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$83.5 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$76.2 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$63.2 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.92B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...